基本信息:
- 专利标题： NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION
- 申请号：US17696997 申请日：2022-03-17
- 公开(公告)号：US20220202729A1 公开(公告)日：2022-06-30
- 发明人： Ola CAMBER , Christina JOHANSSON
- 申请人： VICORE PHARMA AB
- 申请人地址： SE Stockholm
- 专利权人： VICORE PHARMA AB
- 当前专利权人： VICORE PHARMA AB
- 当前专利权人地址： SE Stockholm
- 优先权： GB2006074.5 20200424
- 主分类号： A61K9/48
- IPC分类号： A61K9/48 ; A61K31/4178 ; A61K9/00
摘要：
According to the invention there is provided a pharmaceutical composition comprising N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide (C21), or a pharmaceutically-acceptable salt thereof, in which composition the C21 or salt thereof is protected by the presence of a coating comprising an enteric substance. Preferred dosage forms comprise capsules in which C21 or salt thereof is presented in the form of a dry powder mixture or a suspension of particles of C21 in a solvent in which it is insoluble. Such dosage forms find utility in the treatment of lung diseases, such as idiopathic pulmonary fibrosis, sarcoidosis and respiratory virus-induced tissue damage.
公开/授权文献:
- US11654115B2 Delayed release composition for peroral administration 公开/授权日：2023-05-23
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61K | 医用、牙科用或梳妆用的配制品 |
| ------A61K9/00 | 以特殊物理形状为特征的医药配制品 |
| --------A61K9/48 | .胶囊制剂，例如用明胶、巧克力制造的 |